| Identification | Back Directory | [Name]
Emopamil | [CAS]
78370-13-5 | [Synonyms]
Sz-45
Emopamil
5-[methyl(2-phenylethyl)amino]-2-phenyl-2-propan-2-ylpentanenitrile
α-(1-Methylethyl)-α-[3-[methyl(2-phenylethyl)amino]propyl]benzeneacetonitrile
Benzeneacetonitrile, α-(1-methylethyl)-α-[3-[methyl(2-phenylethyl)amino]propyl]-
Benzeneacetonitrile, a-(1-methylethyl)-a-[3-[methyl(2-phenylethyl)amino]propyl]- | [Molecular Formula]
C23H30N2 | [MOL File]
78370-13-5.mol | [Molecular Weight]
334.5 |
| Hazard Information | Back Directory | [Uses]
Emopamil is an inhibitor of calcium channel that can reduce ischemia-induced neuronal cell damage[1]. | [Definition]
ChEBI: Emopamil is an organic amino compound and a member of benzenes. | [IC 50]
Human Endogenous Metabolite | [References]
[1] G W Bielenberg, et al. Effects of emopamil on postischemic blood flow and neuronal damage in rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb;339(1-2):230-5. DOI:10.1007/BF00165148 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
| Company Name: |
Leancare Ltd.
|
| Tel: |
+33 962096793 |
| Website: |
www.leancare.co.uk |
|